natgillin/translations-raw huggingface dataset:
The active substance is a dry extract from birch bark.
Toimeaine on kasetohu kuivekstrakt.
The active substance is abiraterone acetate.
Toimeaine on abirateroonatsetaat.
The active substance is aclidinium bromide.
Toimeaine on aklidiinbromiid.
The active substance is afamelanotide.
Toimeaine on afamelanotiid.
The active substance is afatinib.
Toimeaine on afatiniib.
The active substance is aflibercept.
Toimeaine on aflibertsept.
The active substance is agalsidase alfa.
Toimeaine on alfaagalsidaas.
The active substance is agalsidase beta, one vial contains 35 mg.
Toimeaine on beetaagalsidaas, üks viaal sisaldab 35 mg.
The active substance is agalsidase beta, one vial contains 5 mg.
Toimeaine on beetaagalsidaas, üks viaal sisaldab 5 mg.
The active substance is agomelatine.
Toimeaine on agomelatiin.
The active substance is albiglutide.
Toimeaine on albiglutiid.
The active substance is alglucosidase alfa.
Toimeaine on alfaalglükosidaas.
The active substance is alirocumab.
Toimeaine on alirokumab.
The active substance is aliskiren (as hemifumarate) 150 mg.
Toimeaine on aliskireen (hemifumaraadina) 150 mg
The active substance is aliskiren (as hemifumarate) 300 mg.
Toimeaine on aliskireen (hemifumaraadina) 300 mg
The active substance is aliskiren (as hemifumarate).
Toimeaine on aliskireen (hemifumaraadina).
The active substance is alitretinoin.
Toimeaine on alitretinoiin.
The active substance is alogliptin.
Mida Vipidia sisaldab Toimeaine on alogliptiin.
The active substance is amifampridine.
Toimeaine on amifampridiin.
The active substance is anakinra.
Toimeaine on anakinra.
The active substance is anidulafungin.
Toimeaine on anidulafungiin.
The active substance is apixaban.
Toimeaine on apiksabaan.
The active substance is apremilast.
Toimeaine on apremilast.
The active substance is aprepitant.
Toimeaine on aprepitant.
The active substance is arsenic trioxide 1 mg/ml
Toimeaine on arseentrioksiid 1 mg/ml
The active substance is asenapine.
Toimeaine on asenapiin.
The active substance is asparaginase.
Toimeaine on asparaginaas.
The active substance is atazanavir.
Toimeaine on atasanaviir.
The active substance is atosiban.
Toimeaine on atosibaan.
The active substance is atosiban.
Toimeaine on: atosibaan.
The active substance is autologous (the patient’s own) CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence.
Toimeaine on autoloogne (patsiendi enda) CD34+ rikastatud rakufraktsioon, mis sisaldab CD34+ rakke, mida on transdutseeritud inimese ADA kodeerivat cDNA järjestust sisaldava retroviirusvektoriga.
The active substance is avanafil.
Toimeaine on avanafiil.
The active substance is axitinib.
Toimeaine on aksitiniib.
The active substance is azacitidine.
Toimeaine on asatsitidiin.
The active substance is azilsartan medoxomil (as potassium) either 20 mg, 40 mg or 80 mg
Toimeaine on asilsartaanmedoksomiil (kaaliumina) 20 mg, 40 mg või 80 mg
The active substance is azilsartan medoxomil (as potassium).
Toimeaine on asilsartaanmedoksomiil (kaaliumina).
The active substance is basiliximab.
Toimeaine on basiliksimab.
The active substance is bedaquiline.
Toimeaine on bedakviliin.
The active substance is betaine anhydrous.
Toimeaine on veevaba betaiin.
The active substance is bevacizumab.
Toimeaine on bevatsizumab.
The active substance is bimatoprost.
Toimeaine on bimatoprost.
The active substance is bivalirudin.
Toimeaine on bivalirudiin.
The active substance is blinatumomab.
Toimeaine on blinatumomab.
The active substance is boceprevir.
Toimeaine on botsepreviir.
The active substance is bosentan as monohydrate.
Toimeaine on bosentaanmonohüdraat.
The active substance is brimonidine.
Toimeaine on brimonidiin.
The active substance is brinzolamide.
Toimeaine on brinsolamiid.
The active substance is bromfenac.
Toimeaine on bromofenak.
The active substance is busulfan.
Toimeaine on busulfaan.
The active substance is C1 inhibitor produced from the plasma of human donors.
Toimeaine on inimdoonorite vereplasmast valmistatud C1 inhibiitor.
The active substance is cabazitaxel.
Toimeaine on kabasitakseel.
The active substance is called levetiracetam.
Toimeaine on levetiratsetaam
The active substance is called levetiracetam.
Toimeaine on levetiratsetaam.
The active substance is canagliflozin.
Toimeaine on kanagliflosiin.
The active substance is canakinumab.
Toimeaine on kanakinumab.
The active substance is capecitabine.
Toimeaine on kapetsitabiin.
The active substance is carfilzomib.
Toimeaine on karfilsomiib.
The active substance is carglumic acid.
Toimeaine on kargluumhape.
The active substance is caspofungin.
Toimeaine on kaspofungiin.
The active substance is catridecacog* (recombinant coagulation factor XIII: 2500 IU/3 ml, after reconstitution, corresponding to a concentration of 833 IU/ml.
Toimeaine on katridekakog* (rekombinantne hüübimisfaktor XIII: 2500 RÜ/3 ml, pärast lahustamist vastab see kontsentratsioonile 833 RÜ/ml).
The active substance is catumaxomab (10 micrograms in 0.1 ml, corresponding to 0.1 mg/ml).
Toimeaine on katumaksomab (10 mikrogrammi 0,1 ml-s, millele vastab 0,1 mg/ml).
The active substance is catumaxomab (50 micrograms in 0.5 ml, corresponding to 0.1 mg/ml).
Toimeaine on katumaksomab (50 mikrogrammi 0,5 ml-s, millele vastab 0,1 mg/ml).
The active substance is celecoxib
Toimeaine on tselekoksiib.
The active substance is certolizumab pegol.
Toimeaine on tsertolizumab pegool.
The active substance is cetrorelix acetate.
Toimeaine on tsetroreliksatsetaat.
The active substance is cetuximab.
Toimeaine on tsetuksimab.
The active substance is cholic acid.
Toimeaine on koolhape.
The active substance is choriogonadotropin alfa, produced by recombinant DNA technology.
Toimeaine on alfakooriongonadotropiin, mida valmistatakse rekombinantse DNA tehnoloogia abil.
The active substance is choriogonadotropin alfa, produced by recombinant DNA technology.
Toimeaine on alfakooriongonadotropiin, mis on toodetud rekombinantse DNA tehnoloogia abil.
The active substance is ciclosporin.
Toimeaine on tsüklosporiin.
The active substance is cobimetinib.
Toimeaine on kobimetiniib.
The active substance is colesevelam (as hydrochloride).
Toimeaine on kolesevelaam (vesinikkloriidina).
The active substance is colestilan.
Toimeaine on kolestilaan.
The active substance is collagenase clostridium histolyticum.
Toimeaine on Clostridium histolyticum’i kollagenaas.
The active substance is copper (64Cu) chloride.
Toimeaine on vask(64Cu)kloriid.
The active substance is corifollitropin alfa.
Toimeaine on alfakorifollitropiin.
The active substance is cysteamine (as mercaptamine bitartrate).
Toimeaine on tsüsteamiin (merkaptamiinbitartraadina).
The active substance is cysteamine bitartrate (mercaptamine bitartrate).
Toimeaine on tsüsteamiinbitartraat (merkaptamiinbitartraat).
The active substance is cytarabine.
Toimeaine on tsütarabiin.
The active substance is dabigatran, which is administered in the form of 110 mg dabigatran etexilate given as mesilate.
Toimeaine on dabigatraan, mida kasutatakse 110 mg dabigatraaneteksilaadina mesülaadi vormis.
The active substance is dabigatran, which is administered in the form of 150 mg dabigatran etexilate given as mesilate.
Toimeaine on dabigatraan, mida kasutatakse 150 mg dabigatraaneteksilaadina mesülaadi vormis.
The active substance is dabigatran, which is administered in the form of 75 mg dabigatran etexilate given as mesilate.
Toimeaine on dabigatraan, mida kasutatakse 75 mg või 110 mg dabigatraaneteksilaadina mesülaadi vormis.
The active substance is dabrafenib.
Toimeaine on dabrafeniib.
The active substance is daclizumab.
Toimeaine on daklitsumab.
The active substance is dalbavancin.
Toimeaine on dalbavantsiin.
The active substance is dapagliflozin.
Toimeaine on dapagliflosiin.
The active substance is daptomycin.
Toimeaine on daptomütsiin.
The active substance is daratumumab.
Toimeaine on daratumumab.
The active substance is darbepoetin alfa, r-HuEPO (erythropoietin produced by gene technology).
Toimeaine on alfadarbepoetiin, r-HuEPO (geenitehnoloogia abil toodetud erütropoetiin).
The active substance is darunavir.
Toimeaine on darunaviir.
The active substance is decitabine.
Toimeaine on detsitabiin.
The active substance is deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one), a bidentate ligand which binds to iron in a 3:1 molar ratio.
Toimeaineks on deferiproon (3-hüdroksü-1,2-dimetüülpüridiin-4-üks), bidentaatne ligand, mis seostub rauaga molaarsuhtes 3:1.
The active substance is deferiprone.
Toimeaine on deferiproon.
The active substance is defibrotide.
Toimeaine on defibrotiid.
The active substance is degarelix.
Toimeaine on degareliks.
The active substance is denosumab.
Toimeaine on denosumab.
The active substance is desloratadine 0.5 mg/ml
Toimeaine on desloratadiin 0,5 mg/ml.
The active substance is desloratadine 2.5 mg
Toimeaine on desloratadiin 2,5 mg.
The active substance is desloratadine 5 mg
Toimeaine on desloratadiin 5 mg.
The active substance is desloratadine 5 mg.
Toimeaine on desloratadiin 5 mg
The active substance is desloratadine.
Toimeaine on desloratadiin.
The active substance is dexamethasone.
Toimeaine on deksametasoon.
The active substance is dexmedetomidine.
Toimeaine on deksmedetomidiin.
The active substance is dexrazoxane.
Toimeaine on deksrasoksaan.
The active substance is dimethyl fumarate.
Mida Tecfidera sisaldab Toimeaine on dimetüülfumaraat.
The active substance is dinutuximab.
Toimeaine on dinutuksimab.
The active substance is docetaxel (as trihydrate).
Toimeaine dotsetakseel (trihüdraadina).
The active substance is docetaxel (as trihydrate).
Toimeaine dotsetakseeli (trihüdraadina).
The active substance is docetaxel (as trihydrate).
Toimeaine on dotsetakseel (trihüdraadina).
The active substance is docetaxel (as trihydrate).
Toimeaine on dotsetakseeli (trihüdraadina).
The active substance is docetaxel anhydrous.
Toimeaine on veevaba dotsetakseel.
The active substance is docetaxel.
Toimeaine dotsetakseel.
The active substance is docetaxel.
Toimeaine on dotsetakseel.
The active substance is dolutegravir.
Toimeaine on dolutegraviir.
The active substance is doripenem.
Toimeaine on doripeneem.
The active substance is doxorubicin hydrochloride.
Toimeaine on doksorubitsiinvesinikkloriid.
The active substance is dulaglutide.
Toimeaine on dulaglutiid.
The active substance is duloxetine.
Mida ARICLAIM sisaldab Toimeaine on duloksetiin.
The active substance is duloxetine.
Mida Cymbalta sisaldab Toimeaine on duloksetiin.
The active substance is duloxetine.
Mida Duloxetine Mylan sisaldab: Toimeaine on duloksetiin.
The active substance is duloxetine.
Mida Xeristar sisaldab: Toimeaine on duloksetiin.
The active substance is duloxetine.
Mida YENTREVE sisaldab Toimeaine on duloksetiin.
The active substance is eculizumab (300 mg/30 ml in a vial corresponding to 10 mg/ml).
Toimeaine on ekulizumab (300 mg / 30 ml viaalis, mis vastab sisaldusele 10 mg/ml).
The active substance is edoxaban (as tosilate).
Toimeaine on edoksabaan (tosilaadina).
The active substance is efalizumab, each vial contains a deliverable dose of 125 mg efalizumab.
Toimeaine on efalizumab, iga viaal sisaldab manustamiseks kättesaadava annusena 125 mg efalizumabi.
The active substance is efmoroctocog alfa (recombinant coagulation factor VIII, Fc fusion protein).
Toimeaine on alfaefmoroktokog (rekombinantne VIII hüübimisfaktor, Fc fusioonvalk).
The active substance is eftrenonacog alfa (recombinant coagulation factor IX, Fc fusion protein).
Toimeaine on alfaeftrenonakog (rekombinantne IX hüübimisfaktor, Fc fusioonvalk).
The active substance is eliglustat (as tartrate).
Toimeaine on eliglustaat (tartraadina).
The active substance is elosulfase alfa.
Toimeaine on alfaelosulfaas.
The active substance is eluxadoline.
Toimeaine on eluksadoliin.
The active substance is elvitegravir.
Toimeaine on elvitegraviir.
The active substance is emedastine 0.5 mg/ml as difumarate.
Toimeaine on emadastiin 0,5 mg/ml difumaraadina
The active substance is empagliflozin.
Toimeaine on empagliflosiin.
The active substance is emtricitabine.
Toimeaine on emtritsitabiin.
The active substance is enfuvirtide.
Toimeaine on enfuvirtiid.
The active substance is enoxaparin sodium.
Toimeaine on naatriumenoksapariin.
The active substance is entacapone.
Toimeaine on entakapoon.
The active substance is epoetin beta.
Toimeaine on epoetiin beeta.
The active substance is epoetin beta.
Toimeaineks on epoetiin beeta.
The active substance is epoetin theta.
Toimeaine on teetaepoetiin
The active substance is epoetin zeta (produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell line).
Toimeaine on dzeetaepoetiin (toodetud rekombinantse DNA tehnoloogiaga CHO (hiina hamstri munasarja) rakuahelas).
The active substance is epoetin zeta (produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell line).
Toimeaine on dzeetaepoetiin (toodetud rekombinantse DNA tehnoloogiaga hiina hamstri munasarja (CHO) rakuahelas).
The active substance is eptifibatide.
Toimeaine on eptifibatiid.
The active substance is eribulin.
Toimeaine on eribuliin.
The active substance is eslicarbazepine acetate.
Toimeaine on eslikarbasepiinatsetaat.
The active substance is esomeprazole.
Toimeaine on esomeprasool.
The active substance is etravirine.
Toimeaine on etraviriin.
The active substance is evolocumab.
Toimeaine on evolokumab.
The active substance is exenatide.
Toimeaine on eksenatiid.
The active substance is fampridine.
Toimeaine on fampridiin.
The active substance is fesoterodine fumarate.
Toimeaine on fesoterodiinfumaraat.
The active substance is fidaxomicin.
Toimeaine on fidaksomitsiin.
The active substance is filgrastim.
Toimeaine on filgrastiim.
The active substance is fingolimod.
Toimeaine on fingolimood.
The active substance is florbetaben (18F).
Toimeaine on florbetabeen (18F).
The active substance is florbetapir (18F).
Toimeaine on florbetapiir (18F).
The active substance is flutemetamol (18F).
Toimeaine on flutemetamool (18F).
The active substance is follitropin alfa.
Toimeaine on alfafollitropiin.
The active substance is fosamprenavir.
Toimeaine on fosamprenaviir.
The active substance is fosaprepitant.
Toimeaine on fosaprepitant.
The active substance is fulvestrant.
Toimeaine on fulvestrant.
The active substance is gadoversetamide.
Toimeaine on gadoversetamiid.
The active substance is galsulfase.
Toimeaine on galsulfaas.
The active substance is ganirelix (0.25 mg in 0.5 mL solution).
Toimeaine on ganireliks (0,25 mg 0,5 ml lahuses).
The active substance is gefitinib.
Toimeaine on gefitiniib.
The active substance is glycerol phenylbutyrate.
Toimeaine on glütseroolfenüülbutüraat.
The active substance is glycopyrronium bromide.
Toimeaine on glükopürrooniumbromiid.
The active substance is histamine dihydrochloride.
Toimeaine on histamiindihüdrokloriid.
The active substance is human coagulation factor IX.
Toimaine on inimese IX verehüübimisfaktor.
The active substance is human coagulation factor IX.
Toimeaine on inimese IX verehüübimisfaktor.
The active substance is human hepatitis B immunoglobulin 500 IU/ml.
Toimeaine on inimese B-hepatiidi immunoglobuliin 500 RÜ/ml.
The active substance is Human hepatitis B immunoglobulin.
Toimeaine on hepatiit B humaanimmunoglobuliin.
The active substance is human insulin.
Toimeaine on humaaninsuliin.
The active substance is human normal immunoglobulin (antibodies of the type IgG).
Toimeaine on inimese normaalne immunoglobuliin (IgG tüüpi antikehad).
The active substance is human normal immunoglobulin (IVIg).
Toimeaine on inimese normaalimmuunglobuliin (IVIg).
The active substance is human normal immunoglobulin.
Toimeaine on inimese normaalne immunoglobuliin.
The active substance is human protein C
Toimeaine on inimese proteiin C
The active substance is hydroxocobalamin.
Toimeaine on hüdroksükobalamiin.
The active substance is hydroxycarbamide.
Toimeaine on hüdroksükarbamiid.
The active substance is ibandronic acid.
Toimeaine on ibandroonhape.
The active substance is ibritumomab tiuxetan.
Toimeaine on ibritumomabtiuksetaan.
The active substance is ibrutinib.
Toimeaine on ibrutiniib.
The active substance is ibuprofen.
Toimeaine on ibuprofeen.
The active substance is icatibant.
Toimeaine on ikatibant.
The active substance is idarucizumab.
Toimeaine on idarutsizumab.
The active substance is idebenone.
Toimeaine on idebenoon.
The active substance is idelalisib.
Toimeaine on idelalisiib.
The active substance is iloprost.
Toimeaine on iloprost.
The active substance is imatinib (as mesilate).
Toimeaine on imatiniib (mesilaadina).
The active substance is imatinib (as mesilate).
Toimeaine on imatiniib (mesülaadina).
The active substance is imatinib (as mesilate).
Toimeaine on imatiniibmesülaat.
The active substance is imatinib mesilate.
Toimeaine on imatiniibmesilaat.
The active substance is imatinib mesilate.
Toimeaine on imatiniibmesülaat.
The active substance is imiglucerase.
Toimeaine on imiglütseraas.
The active substance is imiquimod.
Toimeaine on imikvimood.
The active substance is indinavir.
Toimeaine on indinaviir.
The active substance is infliximab.
Toimeaine on infliksimab.
The active substance is ingenol mebutate.
Toimeaine on ingenoolmebutaat.
The active substance is insulin aspart.
Toimeaine on aspartinsuliin (insulinum aspartum).
The active substance is insulin aspart.
Toimeaine on aspartinsuliin.
The active substance is insulin degludec.
Toimeaine on degludek-insuliin.
The active substance is insulin detemir.
Toimeaine on detemirinsuliin.
The active substance is insulin glargine.
Toimeaine on glargiin-insuliin.
The active substance is insulin glulisine.
Toimeaine on insuliinglulisiin.
The active substance is insulin human made by recombinant biotechnology.
Toimeaine on humaaninsuliin, mis on valmistatud rekombinantse DNA tehnoloogiat kasutades.
The active substance is insulin human.
Toimeaine on humaaninsuliin.
The active substance is insulin human.
Toimeaine on iniminsuliin.
The active substance is insulin lispro.
Toimeaine on lispro-insuliin.
The active substance is interferon beta-1a.
Toimeaine on beeta-1a-interferoon.
The active substance is interferon beta-1b.
Toimeaine on beeta-1b interferoon.
The active substance is ipilimumab.
Toimeaine on ipilimumab.
The active substance is irbesartan.
Toimeaine on irbesaartaan.
The active substance is irinotecan hydrochloride trihydrate.
Toimeaine on irinotekaanvesinikkloriidtrihüdraat.
The active substance is iron as ferumoxytol 30 mg/ml.
Toimeaine on raud 30 mg/ml ferumoksütoolina.
The active substance is isavuconazole.
Ravimi toimeaine on isavukonasool.
The active substance is ivabradine (as hydrochloride).
Toimeaine on ivabradiin (hüdrokloriidina).
The active substance is ixekizumab.
Toimeaine on iksekizumab.
The active substance is ketoconazole.
Toimeaine on ketokonasool.
The active substance is lacosamide.
Toimeaine on lakosamiid.
The active substance is laronidase.
Toimeaine on laronidaas.
The active substance is lasofoxifene.
Toimeaine on lasofoksifeen.
The active substance is leflunomide.
Toimeaine on leflunomiid.
The active substance is lenalidomide.
Toimeaine on lenalidomiid.
The active substance is lenvatinib.
Toimeaine on lenvatiniib.
The active substance is lepirudin, a recombinant DNA product derived from yeast cells.
Toimeaine on lepirudiin (lepirudin), pärmirakkudest saadud rekombinantse DNA produkt.
the active substance is lesinurad. each Zurampic 200 mg film-coated tablet (tablet) contains 200 mg of lesinurad.
toimeaine on lesinuraad. üks Zurampic 200 mg õhukese polümeerikattega tablett (tablett) sisaldab 200 mg lesinuraadi.
The active substance is levetiracetam.
Toimeaine on levetiratsetaam.
The active substance is levofloxacin.
Toimeaine on levofloksatsiin.
The active substance is linaclotide.
Toimeaine on linaklotiid.
The active substance is linagliptin
Toimeaine on linagliptiin
The active substance is lipegfilgrastim.
Toimeaine on lipegfilgrastiim.
The active substance is liposome–encapsulated doxorubicin.
Toimeaine on liposoomkattega doksorubitsiin.
The active substance is liraglutide.
Toimeaine on liraglutiid.
The active substance is lixisenatide.
Toimeaine on liksisenatiid.
The active substance is lomitapide.
Toimeaine on lomitapiid.
The active substance is lurasidone.
Toimeaine on lurasidoon.
The active substance is Lutetium (177Lu) chloride.
Toimeaine on luteetsium(177Lu)kloriid.
The active substance is lutropin alfa.
Toimeaine on lutropiin alfa.
The active substance is macitentan.
Toimeaine on matsitentaan.
The active substance is mecasermin.
Toimeaine on mekasermiin.
The active substance is melatonin.
Toimeaine on melatoniin.
The active substance is memantine.
Toimeaine on memantiin.
The active substance is methoxy polyethylene glycol-epoetin beta.
Toimeaine on metoksüpolüetüleenglükool-epoetiin beeta.
The active substance is methylnaltrexone bromide.
Toimeaine on metüülnaltreksoonbromiid.
The active substance is methylthioninium chloride.
Toimeaine on metüültioniinkloriid.
The active substance is micafungin (as sodium).
Toimeaine on mikafungiin (mikafungiinnaatriumina).
The active substance is midazolam
Toimeaine on midasolaam:
The active substance is mifamurtide.
Toimeaine on mifamurtiid.
The active substance is migalastat.
Toimeaine on migalastaat.
The active substance is mirabegron.
Toimeaine on mirabegroon.
The active substance is mitotane.
Toimeaine on mitotaan.
The active substance is Modified Vaccinia Ankara – Bavarian Nordic Live virus1, no less than 5 x 107 TCID50*
Toimeaine on modifitseeritud vaktsiiniaviirus Ankara –Bavarian Nordic elusviirus1, mitte vähem kui 5 x 107 TCID50
The active substance is moroctocog alfa (recombinant coagulation factor VIII).
Toimeaine on alfamoroktokog (rekombinantne VIII hüübimisfaktor).
The active substance is mycophenolate mofetil.
Toimeaine on 500 mg mükofenolaatmofetiil.
The active substance is mycophenolate mofetil.
Toimeaine on mükofenolaatmofetiil.
The active substance is naloxegol.
Toimeaine on naloksegool.
The active substance is nateglinide.
Toimeaine on nategliniid.
The active substance is necitumumab.
Toimeaine on netsitumumab.
The active substance is nepafenac.
Toimeaine on nepafenak.
The active substance is nevirapine.
Toimeaine on nevirapiin.
The active substance is nilotinib.
Toimeaine on nilotiniib.
The active substance is nitisinone.
Toimeaine on nitisinoon.
The active substance is nonacog alfa (recombinant coagulation factor IX).
Toimeaine on nonakog alfa (rekombinantne IX hüübimisfaktor).
The active substance is nonacog gamma (recombinant human coagulation Factor IX).
Toimeaine on gammanonakog (rekombinantne inimese IX hüübimisfaktor).
The active substance is obinutuzumab: 1,000 mg/40 mL per vial corresponding to a concentration before dilution of 25 mg/mL.
Toimeaine on obinutuzumab: 1000 mg/40 ml viaali kohta, mis vastab lahjendamiseelsele kontsentratsioonile 25 mg/ml.
The active substance is ocriplasmin.
Toimeaine on okriplasmiin.
The active substance is octocog alfa (human coagulation Factor VIII produced by recombinant DNA technology).
Toimeaine on oktokog alfa (rekombinantne inimese hüübimisfaktor VIII, mis on toodetud rekombinantse DNA tehnoloogia abil).
The active substance is ofatumumab.
Toimeaine on ofatumumab.
The active substance is olanzapine
Toimeaine on olansapiin
The active substance is olanzapine.
Mida ZYPADHERA sisaldab Toimeaine on olansapiin.
The active substance is olaratumab.
Toimeaine on olaratumab.
The active substance is omalizumab.
Toimeaine on omalizumab.
The active substance is opicapone.
Toimeaine on opikapoon.
The active substance is oritavancin.
Toimeaine on oritavantsiin.
The active substance is orlistat.
Toimeaine on orlistat.
The active substance is oseltamivir (12 mg/ml oseltamivir after reconstitution).
Toimeaine on oseltamiviir (12 mg/ml oseltamiviiri pärast valmistamist).
The active substance is oseltamivir (6 mg/ml oseltamivir after reconstitution).
Toimeaine on oseltamiviir (6 mg/ml oseltamiviiri pärast valmistamist).
The active substance is osimertinib (as mesylate).
Toimeaine on osimertiniib (mesilaadina).
The active substance is ospemifene.
Toimeaine on ospemifeen.
The active substance is palifermin.
Toimeaine on palifermiin.
The active substance is paliperidone
Toimeaine on paliperidoon.
The active substance is palivizumab.
Toimeaine on palivisumab.
The active substance is palonosetron (as hydrochloride).
Toimeaine on palonosetroon (vesinikkloriidina).